Table 3.
Self-Report Measure | Time Point (wks) |
LS Mean Change [95% CI] | Trt Diffb | |||
---|---|---|---|---|---|---|
Oxytocin N = 32 |
Placebo N = 30 |
|||||
Interpersonal Reactivity Index | ||||||
Fantasy | 6 | −0.8 | [−2.4, 0.8] | −1.5 | [−3.1, 0.1] | 0.7 |
12 | −1.3 | [−2.9, 0.4] | −1.1 | [−2.7, 0.5] | −0.2 | |
Emotional Concern | 6 | −1.2 | [−2.5, 0.1] | −1.4a | [−2.7, −0.1] | 0.2 |
12 | −1.2 | [−2.5, 0.1] | −1.1 | [−2.3, 0.2] | −0.1 | |
Perspective Taking | 6 | −0.4 | [−1.9, 1.0] | −1.4 | [−2.8, 0.1] | 1 |
12 | 0.4 | [−1.1, 1.9] | −1.8a | [−3.3, −0.4] | 2.2 | |
Personal Distress | 6 | 0.6 | [−0.9, 2.1] | −0.4 | [−1.8, 1.1] | 1 |
12 | 0.2 | [−1.3, 1.7] | −0.3 | [−1.8, 1.1] | 0.5 | |
Lieberman Anxiety Scale | ||||||
Total | 6 | −0.3 | [−8.3, 7.7] | −1.6 | [−9.7, 6.4] | 1.3 |
12 | −1.3 | [−9.6, 6.9] | −8.0 | [−16.1, 0.2] | 6.7 | |
Fear | 6 | −0.2 | [−4.6, 4.2] | 1.7 | [−2.7, 6.0] | −1.9 |
12 | −0.7 | [−5.2, 3.8] | −1.6 | [−5.9, 2.8] | 0.9 | |
Avoidance | 6 | −0.1 | [−4.3, 4.0] | −3.7 | [−7.8, 0.5] | 3.6 |
12 | −0.6 | [−4.9, 3.7] | −5.4 | [−9.5, −1.3] | 4.8 | |
Social Fear | 6 | −0.1 | [−2.4, 2.2] | −0.1 | [−2.4, 2.2] | 0 |
12 | −0.6 | [−2.9, 1.8] | −1.4 | [−3.7, 0.9] | 0.8 | |
Social Avoidance | 6 | 0.4 | [−1.6, 2.3] | −1.2 | [−3.1, 0.8] | 1.6 |
12 | −0.1 | [−2.0, 1.9] | −2.7a | [−4.6, −0.7] | 2.6 | |
Performance Fear | 6 | −0.1 | [−2.6, 2.3] | 1.7 | [−0.7, 4.2] | −1.8 |
12 | −0.2 | [−2.7, 2.4] | −0.2 | [−2.6, 2.2] | 0 | |
Performance Av | 6 | −0.5 | [−2.9, 1.8] | −1.1 | [−3.4, 1.3] | 0.6 |
12 | −0.6 | [−3.0, 1.8] | −1.9 | [−4.2, 0.5] | 1.3 | |
Green Paranoid Thought Scale | ||||||
Social Reference | 6 | −0.3 | [−3.8, 3.2] | −4.7a | [−8.2, −1.2] | 4.4 |
12 | −0.3 | [−3.8, 3.3] | −3.5 | [−6.9, 0.1] | 3.2 | |
Persecution | 6 | −0.2 | [−4.1, 3.9] | −3.4 | [−7.4, 0.6] | 3.2 |
12 | −0.9 | [−5.0, 3.3] | −2.1 | [−6.1, 1.8] | 1.2 | |
Total | 6 | −0.4 | [−6.9, 6.2] | −8.1a | [−14.6, −1.7] | 7.7 |
12 | −1.0 | [−7.7, 5.7] | −5.6 | [−12.1, 0.8] | 4.6 |
Note: Bold values indicate significant between group differences, p <.05.
Indicates significant within group differences.
Values reflect differences between treatment groups, i.e., oxytocin group compared with the placebo group, at each time point. Models adjusted for baseline value, age, and baseline PANSS social items.